COVID-19 is currently affecting the entire world, and doctors are still trying to find the cure and vaccines. Thousands of people have already died from this highly contagious disease, and the population can only rely on protections that can help lessen the chances of getting infected.
People today can’t freely go out of their homes. They can’t travel, and even going to markets to buy food is risky due to the virus, but there is no vaccine yet, so everyone needs to live with it, at least for now. Wearing a face mask, face shield, and social distancing are considered as the new normal today and people have to follow or be infected.
A new study on blood types and COVID-19
In the quest to find COVID-19 cure and preventive medicines that can boost immunity to the disease, scientists and doctors continue to work round-the-clock. As they do their research, they are also discovering many things, and in one of the newest studies, it was revealed that individuals with blood type O may have a lower risk of getting infected.
It was added that these people are also likely to get severely sick. This simply means that those with blood type O have a great advantage in this time of pandemic and from severe illnesses.
CNN News reported that a Danish study discovered this after noticing that in over 7,400 people who tested positive for COVID-19, only 38 percent of them have blood type O. It was said that around 41 percent of the 2.2 million population has this blood type.
In a separate study conducted in Canada, it was found that in 95 patients who are critically ill in the ICUs have blood types A or AB. In comparison to those who have type O, they also stay much longer in the intensive care unit.
What this study means
This research that was published in the American Society of Hematology’s Journal Blood Advances provides evidence that blood types also play a role in people’s immunity and susceptibility to infections like COVID-19. It also has an effect on how serious their illness could get or heal.
Then again, more testings and research are needed for this study as the exact reasons for such findings are not yet clear. Scientists will look into this discovery further so they can conclude why people with blood type O are less affected by severe illnesses or infections.
"As a clinician, it is at the back of my mind when I look at patients and stratify them,” Dr. Mypinder Sekhon, the author of the Canadian study said. “But in terms of a definitive marker, we need repeated findings across many jurisdictions that show the same thing."


TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Is dark chocolate healthier than milk chocolate? 2 dietitians explain
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 



